Form 4 for CTAS Cintas
Accepted 2021-08-02 00:00:00 ET · period of report 2021-07-29 · accession 0001567619-21-014252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-02 | 2021-07-29 | CTAS | FROOMAN THOMAS E | SVP, Sec, Gen Counsel | S - Sale+OE | $392.46 | -16.9K | 96.8K | -15% | -$6.63M |
| DM | 2021-08-02 | 2021-07-29 | CTAS | FROOMAN THOMAS E | SVP, Sec, Gen Counsel | M - OptEx | $148.16 | +25.5K | 96.4K | +36% | +$3.78M |
| DM | 2021-08-02 | 2021-08-02 | CTAS | FROOMAN THOMAS E | SVP, Sec, Gen Counsel | M - OptEx | $0.00 | +25.5K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-29 | S | D | 10,218 | $392.08 | 103,496 | D | — | — | (F1) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $391.68 to $392.68. The Reporting Person undertakes to provide full pricing information to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2021-07-29 | M | A | 7,357 | $206.99 | 113,714 | D | — | — | |
| 3 | Common | Common Stock | 2021-07-29 | S | D | 6,686 | $393.05 | 96,810 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $392.69 to $393.27. The Reporting Person undertakes to provide full pricing information to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request. |
| 4 | Common | Common Stock | 2021-07-29 | M | A | 2,699 | $137.30 | 106,357 | D | — | — | |
| 5 | Common | Common Stock | 2021-07-29 | M | A | 7,301 | $137.30 | 103,658 | D | — | — | |
| 6 | Common | Common Stock | 2021-07-29 | M | A | 8,150 | $108.39 | 96,357 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | M | A | 7,301 | $0.00 | 7,302 | D | $137.30 · — to 2027-07-25 | 7,301 Common Stock | (F3) The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | M | A | 2,699 | $0.00 | 2,700 | D | $137.30 · — to 2027-07-25 | 2,699 Common Stock | (F3) The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | M | A | 7,357 | $0.00 | 14,716 | D | $206.99 · — to 2028-07-24 | 7,357 Common Stock | (F3) The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | M | A | 8,150 | $0.00 | 0 | D | $108.39 · — to 2026-07-26 | 8,150 Common Stock | (F3) The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date. |